Industry Overview
AI-Enabled imaging modalities market was valued at $4.8 billion in 2024 and is anticipated to reach $16.1 billion by 2035 at a CAGR of 15.4% during the forecast period (2025-2035). The market growth is facilitated by increasing incidence of chronic diseases, growing need for early diagnosis, and expanding use of Machine Learning (ML) and Deep Learning (DL) in image interpretation. Healthcare professionals and radiologists are taking advantage of AI tools to improve diagnostic accuracy, minimize human errors, and improve imaging workflows. For instance, in May 2024, NOVIUS, a health care startup company, introduced its revolutionary AI-based technology, N-Vision 3D, that translates two-dimensional images to three-dimensional in real time, and assists in improving surgical procedures. N-Vision 3D has the potential to revolutionize X-ray fluoroscopy system imaging, endoscopic, and angiography. Such progress includes the current 2D endoscopes (monocular cameras) that can be easily integrated with N-Vision 3D without any upgrade.
For Full Report Description + Research Methodology + Table of Contents + Infographics @
https://ai.omrglobal.com/report-gallery/ai-enabled-imaging-modalities-market/
Recent Developments
- In December 2024, Canon Medical Systems launched its new AI-powered automation platform. This is an innovative, zero-click solution that uses deep learning technology to streamline clinical workflows for fast and actionable results. The advancement is designed to seamlessly integrate from scanner to clinical decision-making and empowers healthcare providers with the precise tools they need to help with patient triage and confident treatment planning.
- In November 2024, DeepHealth, Inc., a subsidiary of RadNet, Inc., achieved expanded FDA clearance for the innovative mammography software. The SmartMammo Dx AI algorithm within SmartMammo1 is FDA-cleared to triage breast ultrasound to provide real-time risk scoring to prioritize critical cases.
- In January 2024, GE HealthCare declared an acquisition agreement with MIM Software from Cleveland, an international provider of medical imaging analysis and AI solutions in molecular radiotherapy, urology, radiation oncology, and diagnostic imaging. The acquisition integrates MIM Software’s imaging analytics and digital workflow capabilities across diverse care areas. It aims to improve innovation and distinguish GE HealthCare’s solutions for the betterment of patients and healthcare systems around the world.
Some of the Key Companies in the AI-Enabled Imaging Modalities Market include-
- Agfa-Gevaert Group
- Analogic
- Butterfly Network Inc.
- Canon Medical Systems Corp.
- Carestream Health
- Esaote S.p.A.
- FUJIFILM Corp.
- GE HealthCare Technologies Inc.
- Hitachi Ltd.
- Hologic, Inc.
- Intelerad Medical Systems
- Intrasense
- Koninklijke Philips N.V.
- Mindray Medical International Ltd.
- Pie Medical Imaging B.V.
- Planmed Oy
- Riverain Technologies
- Samsung Healthcare
- Siemens Healthineers
- Toshiba Corp.
- Varian Medical Systems
- ZEBRA
AI-Enabled Imaging Modalities Market Segmentation Analysis
Global AI-Enabled Imaging Modalities Market by Product Type
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- X-Ray
- Ultrasound
- Positron Emission Tomography (PET)
- Single-Photon Emission Computed Tomography (SPECT)
- Others (Hybrid Imaging Modalities, Optical Coherence Tomography (OCT))
Global AI-Enabled Imaging Modalities Market by End-User
- Hospitals
- Diagnostic Centers
- Research Institutions
Global AI-Enabled Imaging Modalities Market by Application
- Cardiology
- Oncology
- Neurology
- Orthopedics
- Gastroenterology
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- ASEAN Economies (Singapore, Thailand, Vietnam, Indonesia, and Other)
- Australia and New Zealand
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- Middle East and Africa
Anurag Tiwari
Director Sales Division
+91 780-304-0404
info@omrglobal.com
Visit us on social media:
Facebook | X | LinkedIn